Aurora-A regulation of nuclear factor-κB signaling by phosphorylation of IκBα

被引:93
|
作者
Briassouli, Paraskevi
Chan, Florence
Savage, Kay
Reis-Filho, Jorge S.
Linardopoulos, Spiros
机构
[1] Breakthrough Breast Canc Res Ctr, Inst Canc Res, London SW3 6JB, England
[2] Canc Res UK, Inst Canc Res, Ctr Canc Therapeut, Belmont, Surrey, England
关键词
D O I
10.1158/0008-5472.CAN-06-2272
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The Aurora-A/STK15 gene encodes a kinase that is frequently amplified in cancer. Overexpression of Aurora-A in mammalian cells leads to centrosome amplification, genetic instability, and transformation. In this study, we show that Aurora-A activates nuclear factor-kappa B (NF-kappa B) via I kappa B alpha phosphorylation. Inhibition of endogenous Aurora-A reduces tumor necrosis factor alpha (TNF alpha)-induced I kappa B alpha degradation. We analyzed primary human breast cancers, and 13.6% of samples showed Aurora-A gene amplification, all of which exhibited nuclear localization of NF-kappa B. We propose that this subgroup of patients with breast cancer might benefit from inhibiting Aurora-A. We also show that down-regulation of NF-kappa B via Aurora-A depletion can enhance cisplatin-dependent apoptosis. These data define a new role for Aurora-A in regulating I kappa B alpha that is critical for the activation of NF-kappa B-directed gene expression and may be partially responsible for the oncogenic effect of Aurora-A when the gene is amplified and overexpressed in human tumors.
引用
收藏
页码:1689 / 1695
页数:7
相关论文
共 50 条
  • [41] Nuclear factor-κB mediates up-regulation of cathepsin B by doxorubicin in tumor cells
    Bien, S
    Ritter, CA
    Gratz, M
    Sperker, B
    Sonnemann, J
    Beck, JF
    Kroemer, HK
    MOLECULAR PHARMACOLOGY, 2004, 65 (05) : 1092 - 1102
  • [42] Regulation of the Aurora-A gene following topoisomerase I inhibition: implication of the Myc transcription Factor
    Courapied, Sandy
    Cherier, Julia
    Vigneron, Arnaud
    Troadec, Marie-Berangere
    Giraud, Sandrine
    Valo, Isabelle
    Prigent, Claude
    Gamelin, Erick
    Coqueret, Olivier
    Barre, Benjamin
    MOLECULAR CANCER, 2010, 9
  • [43] The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways
    Tiejun Zhao
    Long Yang
    Qiang Sun
    Meztli Arguello
    Dean W Ballard
    John Hiscott
    Rongtuan Lin
    Nature Immunology, 2007, 8 : 592 - 600
  • [44] The NEMO adaptor bridges the nuclear factor-κB and interferon regulatory factor signaling pathways
    Zhao, Tiejun
    Yang, Long
    Sun, Qiang
    Arguello, Meztli
    Ballard, Dean W.
    Hiscott, John
    Lin, Rongtuan
    NATURE IMMUNOLOGY, 2007, 8 (06) : 592 - 600
  • [45] Tunicamycin suppresses breast cancer cell growth and metastasis via regulation of the protein kinase B/nuclear factor-κB signaling pathway
    Wang, Xiaoli
    Xiong, Wei
    Tang, Yiyin
    ONCOLOGY LETTERS, 2018, 15 (04) : 4137 - 4142
  • [46] Role of nuclear factor-κB in melanoma
    Amiri, KI
    Richmond, A
    CANCER AND METASTASIS REVIEWS, 2005, 24 (02) : 301 - 313
  • [47] Nuclear factor-κB, cancer, and apoptosis
    Bours, V
    Bentires-Alj, M
    Hellin, AC
    Viatour, P
    Robe, P
    Delhalle, S
    Benoit, V
    Merville, MP
    BIOCHEMICAL PHARMACOLOGY, 2000, 60 (08) : 1085 - 1089
  • [48] Nuclear factor-κB and liver carcinogenesis
    Arsura, M
    Cavin, LG
    CANCER LETTERS, 2005, 229 (02) : 157 - 169
  • [49] Growing old with nuclear factor-κB
    Giardina, C
    Hubbard, AK
    CELL STRESS & CHAPERONES, 2002, 7 (02): : 207 - 212
  • [50] Nuclear factor-κ-B:: The enemy within
    Aggarwal, BB
    CANCER CELL, 2004, 6 (03) : 203 - 208